de Northern Trust BioCryst Pharmaceuticals BCRX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 22.6 M | Comprar |
2,255,731
+151,006
| +7% | +USD 1.37 M | ﹤0.01% | 1731 |
|
|
2026
Q1 | USD 20 M | Comprar |
2,104,725
+247,822
| +13% | +USD 1.92 M | ﹤0.01% | 1679 |
|
|
2025
Q4 | USD 14.5 M | Vender |
1,856,903
-35,140
| -2% | -USD 254 k | ﹤0.01% | 1881 |
|
|
2025
Q3 | USD 14.4 M | Vender |
1,892,043
-21,686
| -1% | -USD 181 k | ﹤0.01% | 1901 |
|
|
2025
Q2 | USD 17.1 M | Vender |
1,913,729
-41,529
| -2% | -USD 387 k | ﹤0.01% | 1735 |
|
|
2025
Q1 | USD 14.7 M | Vender |
1,955,258
-49,653
| -2% | -USD 401 k | ﹤0.01% | 1815 |
|
|
2024
Q4 | USD 15.1 M | Comprar |
2,004,911
+143,986
| +8% | +USD 1.09 M | ﹤0.01% | 1879 |
|
|
2024
Q3 | USD 14.1 M | Comprar |
1,860,925
+106,162
| +6% | +USD 807 k | ﹤0.01% | 1852 |
|
|
2024
Q2 | USD 10.8 M | Vender |
1,754,763
-50,412
| -3% | -USD 278 k | ﹤0.01% | 1947 |
|
|
2024
Q1 | USD 9.17 M | Vender |
1,805,175
-41,591
| -2% | -USD 234 k | ﹤0.01% | 2089 |
|
|
2023
Q4 | USD 11.1 M | Vender |
1,846,766
-5,897
| -0.3% | -USD 34.2 k | ﹤0.01% | 1992 |
|
|
2023
Q3 | USD 13.1 M | Comprar |
1,852,663
+15,142
| +0.8% | +USD 109 k | ﹤0.01% | 1820 |
|
|
2023
Q2 | USD 12.9 M | Comprar |
1,837,521
+74,422
| +4% | +USD 597 k | ﹤0.01% | 1873 |
|
|
2023
Q1 | USD 14.7 M | Comprar |
1,763,099
+15,639
| +0.9% | +USD 151 k | ﹤0.01% | 1759 |
|
|
2022
Q4 | USD 20.1 M | Vender |
1,747,460
-49,331
| -3% | -USD 615 k | ﹤0.01% | 1518 |
|
|
2022
Q3 | USD 22.6 M | Vender |
1,796,791
-20,093
| -1% | -USD 259 k | 0.01% | 1380 |
|
|
2022
Q2 | USD 19.2 M | Comprar |
1,816,884
+16,986
| +0.9% | +USD 175 k | ﹤0.01% | 1549 |
|
|
2022
Q1 | USD 29.3 M | Vender |
1,799,898
-61,110
| -3% | -USD 980 k | 0.01% | 1403 |
|
|
2021
Q4 | USD 25.8 M | Vender |
1,861,008
-576,576
| -24% | -USD 7.63 M | ﹤0.01% | 1594 |
|
|
2021
Q3 | USD 35 M | Vender |
2,437,584
-22,728
| -0.9% | -USD 358 k | 0.01% | 1367 |
|
|
2021
Q2 | USD 38.9 M | Comprar |
2,460,312
+508,184
| +26% | +USD 6.9 M | 0.01% | 1359 |
|
|
2021
Q1 | USD 19.9 M | Vender |
1,952,128
-110,979
| -5% | -USD 1.14 M | ﹤0.01% | 1828 |
|
|
2020
Q4 | USD 15.4 M | Vender |
2,063,107
-27,319
| -1% | -USD 141 k | ﹤0.01% | 1976 |
|
|
2020
Q3 | USD 7.18 M | Comprar |
2,090,426
+162,200
| +8% | +USD 695 k | ﹤0.01% | 2310 |
|
|
2020
Q2 | USD 9.19 M | Comprar |
1,928,226
+59,096
| +3% | +USD 236 k | ﹤0.01% | 2149 |
|
|
2020
Q1 | USD 3.74 M | Comprar |
1,869,130
+38,698
| +2% | +USD 107 k | ﹤0.01% | 2472 |
|
|
2019
Q4 | USD 6.32 M | Comprar |
1,830,432
+462,630
| +34% | +USD 1.16 M | ﹤0.01% | 2455 |
|
|
2019
Q3 | USD 3.92 M | Comprar |
1,367,802
+4,753
| +0.3% | +USD 14.8 k | ﹤0.01% | 2684 |
|
|
2019
Q2 | USD 5.16 M | Comprar |
1,363,049
+2,115
| +0.2% | +USD 12.7 k | ﹤0.01% | 2542 |
|
|
2019
Q1 | USD 11.1 M | Comprar |
1,360,934
+10,318
| +0.8% | +USD 88.3 k | ﹤0.01% | 2080 |
|
|
2018
Q4 | USD 10.9 M | Vender |
1,350,616
-3,217
| -0.2% | -USD 25 k | ﹤0.01% | 2015 |
|
|
2018
Q3 | USD 10.3 M | Comprar |
1,353,833
+139,272
| +11% | +USD 935 k | ﹤0.01% | 2238 |
|
|
2018
Q2 | USD 6.96 M | Comprar |
1,214,561
+25,685
| +2% | +USD 141 k | ﹤0.01% | 2494 |
|
|
2018
Q1 | USD 5.67 M | Comprar |
1,188,876
+13,044
| +1% | +USD 67 k | ﹤0.01% | 2512 |
|
|
2017
Q4 | USD 5.77 M | Comprar |
1,175,832
+164,957
| +16% | +USD 799 k | ﹤0.01% | 2521 |
|
|
2017
Q3 | USD 5.3 M | Comprar |
1,010,875
+4,035
| +0.4% | +USD 20.7 k | ﹤0.01% | 2593 |
|
|
2017
Q2 | USD 5.6 M | Comprar |
1,006,840
+98,077
| +11% | +USD 597 k | ﹤0.01% | 2554 |
|
|
2017
Q1 | USD 7.63 M | Comprar |
908,763
+36,243
| +4% | +USD 252 k | ﹤0.01% | 2301 |
|
|
2016
Q4 | USD 5.52 M | Comprar |
872,520
+16,529
| +2% | +USD 86 k | ﹤0.01% | 2488 |
|
|
2016
Q3 | USD 3.78 M | Vender |
855,991
-7,934
| -0.9% | -USD 31.7 k | ﹤0.01% | 2706 |
|
|
2016
Q2 | USD 2.45 M | Comprar |
863,925
+31,262
| +4% | +USD 97.1 k | ﹤0.01% | 2916 |
|
|
2016
Q1 | USD 2.41 M | Vender |
832,663
-71,123
| -8% | -USD 315 k | ﹤0.01% | 2868 |
|
|
2015
Q4 | USD 9.33 M | Comprar |
903,786
+4,654
| +0.5% | +USD 46.3 k | ﹤0.01% | 2064 |
|
|
2015
Q3 | USD 10.3 M | Comprar |
899,132
+81,651
| +10% | +USD 1.09 M | ﹤0.01% | 1978 |
|
|
2015
Q2 | USD 12.2 M | Vender |
817,481
-11,457
| -1% | -USD 130 k | ﹤0.01% | 1934 |
|
|
2015
Q1 | USD 7.49 M | Vender |
828,938
-10,128
| -1% | -USD 105 k | ﹤0.01% | 2246 |
|
|
2014
Q4 | USD 10.2 M | Vender |
839,066
-2,161
| -0.3% | -USD 23.9 k | ﹤0.01% | 2031 |
|
|
2014
Q3 | USD 8.23 M | Comprar |
841,227
+603,137
| +253% | +USD 7.39 M | ﹤0.01% | 2174 |
|
|
2014
Q2 | USD 3.04 M | Comprar |
238,090
+123,186
| +107% | +USD 1.2 M | ﹤0.01% | 2840 |
|
|
2014
Q1 | USD 1.22 M | Vender |
114,904
-87
| -0.1% | -USD 928 | ﹤0.01% | 3344 |
|
|
2013
Q4 | USD 874 k | Comprar |
114,991
+11,480
| +11% | +USD 72.7 k | ﹤0.01% | 3416 |
|
|
2013
Q3 | USD 753 k | Vender |
103,511
-391,536
| -79% | -USD 1.99 M | ﹤0.01% | 3388 |
|
|
2013
Q2 | USD 767 k | Comprar |
+495,047
| Nuevas | +USD 854 k | ﹤0.01% | 3344 |
|
Otros fondos que tienen BCRX en su cartera
Posición de Northern Trust en BCRX: resumen de T2 2026
Northern Trust aumentó su participación en BioCryst Pharmaceuticals (BCRX) en 7.2% durante T2 2026, al comprar aproximadamente USD 1.37 M y elevar la posición a 2,255,731 acciones con un valor de USD 22.6 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1731.
Northern Trust reportó por primera vez una posición en BCRX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 38.9 M en T2 2021. Al cierre de T2 2026, 320 fondos que sigue Wall St. Rank mantienen una posición en BCRX.
- Al cierre de T2 2026, Northern Trust tenía 2,255,731 acciones de BioCryst Pharmaceuticals con un valor de USD 22.6 M.
- Northern Trust compró 151,006 acciones de BioCryst Pharmaceuticals en T2 2026, por un monto estimado de USD 1.37 M.
- BioCryst Pharmaceuticals representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 1731.
- Northern Trust reportó por primera vez una posición en BioCryst Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en BioCryst Pharmaceuticals alcanzó su máximo de USD 38.9 M en T2 2021.
- Al cierre de T2 2026, 320 fondos que sigue Wall St. Rank tenían BioCryst Pharmaceuticals en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.